Coral Genomics

BioCorteX

This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.

Organo-ID

The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.

Oncosyne

This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.

Imagenomix

The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.

D2G Oncology

This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.

BioReperia

This biotech company provides zebrafish tumor xenograft platforms for pharmaceutical companies and clinicians to accelerate oncology drug discovery and individualise patient treatment plans.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.